News Image

ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences

Provided By GlobeNewswire

Last update: Mar 3, 2025

Company to Host Conference Call on March 20 at 8:30 a.m. ET

SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced the company will host a conference call and webcast on Thursday, March 20, 2025, at 8:30 a.m. ET to discuss its fourth quarter and full year 2024 financial results and business highlights. The dial-in information for conference participants may be obtained by registering for the event.

Read more at globenewswire.com

ARS PHARMACEUTICALS INC

NASDAQ:SPRY (4/25/2025, 8:00:02 PM)

After market: 13.85 +0.08 (+0.58%)

13.77

-0.87 (-5.94%)



Find more stocks in the Stock Screener

Follow ChartMill for more